Literature DB >> 21228145

Evaluation of serological diagnostic methods for the 2009 pandemic influenza A (H1N1) virus.

Jesse Papenburg1, Mariana Baz, Marie-Ève Hamelin, Chantal Rhéaume, Julie Carbonneau, Manale Ouakki, Isabelle Rouleau, Gaston De Serres, Guy Boivin.   

Abstract

Serology improves influenza diagnosis by capturing cases missed by reverse transcriptase PCR (RT-PCR). We prospectively evaluated microneutralization and hemagglutination inhibition assays for 2009 influenza A (H1N1) virus diagnosis among 24 RT-PCR-confirmed cases and 98 household contacts. Compared to hemagglutination inhibition, microneutralization demonstrated a higher level of concordance with RT-PCR (kappa = 0.69 versus kappa = 0.60) and greater sensitivity (83% versus 71%; P = 0.016).

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21228145      PMCID： PMC3067392          DOI： 10.1128/CVI.00449-10

Source DB:  PubMed          Journal:  Clin Vaccine Immunol        ISSN： 1556-679X


  16 in total

1.  Pitfalls in diagnosis of pandemic (novel) A/H1N1 2009 influenza.

Authors:  Kamaljit Singh; Shawn Vasoo; Jane Stevens; Paul Schreckenberger; Gordon Trenholme
Journal:  J Clin Microbiol       Date:  2010-02-17       Impact factor: 5.948

2.  Response to a monovalent 2009 influenza A (H1N1) vaccine.

Authors:  Michael E Greenberg; Michael H Lai; Gunter F Hartel; Christine H Wichems; Charmaine Gittleson; Jillian Bennet; Gail Dawson; Wilson Hu; Connie Leggio; Diane Washington; Russell L Basser
Journal:  N Engl J Med       Date:  2009-09-10       Impact factor: 91.245

Review 3.  Does this patient have influenza?

Authors:  Stephanie A Call; Mark A Vollenweider; Carlton A Hornung; David L Simel; W Paul McKinney
Journal:  JAMA       Date:  2005-02-23       Impact factor: 56.272

4.  Household transmission of the 2009 pandemic A/H1N1 influenza virus: elevated laboratory‐confirmed secondary attack rates and evidence of asymptomatic infections.

Authors:  Jesse Papenburg; Mariana Baz; Marie-Ève Hamelin; Chantal Rhéaume; Julie Carbonneau; Manale Ouakki; Isabelle Rouleau; Isabelle Hardy; Danuta Skowronski; Michel Roger; Hugues Charest; Gaston De Serres; Guy Boivin
Journal:  Clin Infect Dis       Date:  2010-11-01       Impact factor: 9.079

5.  Detection of influenza A viruses from different species by PCR amplification of conserved sequences in the matrix gene.

Authors:  R A Fouchier; T M Bestebroer; S Herfst; L Van Der Kemp; G F Rimmelzwaan; A D Osterhaus
Journal:  J Clin Microbiol       Date:  2000-11       Impact factor: 5.948

6.  Contagious period for pandemic (H1N1) 2009.

Authors:  Gaston De Serres; Isabelle Rouleau; Marie Eve Hamelin; Caroline Quach; Danuta Skowronski; Louis Flamand; Nicole Boulianne; Yan Li; Julie Carbonneau; Annemarie Bourgault; Michel Couillard; Hugues Charest; Guy Boivin
Journal:  Emerg Infect Dis       Date:  2010-05       Impact factor: 6.883

7.  Seasonal influenza in adults and children--diagnosis, treatment, chemoprophylaxis, and institutional outbreak management: clinical practice guidelines of the Infectious Diseases Society of America.

Authors:  Scott A Harper; John S Bradley; Janet A Englund; Thomas M File; Stefan Gravenstein; Frederick G Hayden; Allison J McGeer; Kathleen M Neuzil; Andrew T Pavia; Michael L Tapper; Timothy M Uyeki; Richard K Zimmerman
Journal:  Clin Infect Dis       Date:  2009-04-15       Impact factor: 9.079

8.  Sialic acid receptor specificity on erythrocytes affects detection of antibody to avian influenza haemagglutinin.

Authors:  I Stephenson; J M Wood; K G Nicholson; M C Zambon
Journal:  J Med Virol       Date:  2003-07       Impact factor: 2.327

9.  Switching gears for an influenza pandemic: validation of a duplex reverse transcriptase PCR assay for simultaneous detection and confirmatory identification of pandemic (H1N1) 2009 influenza virus.

Authors:  Jason J LeBlanc; Yan Li; Nathalie Bastien; Kevin R Forward; Ross J Davidson; Todd F Hatchette
Journal:  J Clin Microbiol       Date:  2009-09-30       Impact factor: 5.948

10.  Trial of 2009 influenza A (H1N1) monovalent MF59-adjuvanted vaccine.

Authors:  Tristan W Clark; Manish Pareek; Katja Hoschler; Helen Dillon; Karl G Nicholson; Nicola Groth; Iain Stephenson
Journal:  N Engl J Med       Date:  2009-09-10       Impact factor: 91.245
View more
  16 in total

1.  Calcium phosphate nanoparticle (CaPNP) for dose-sparing of inactivated whole virus pandemic influenza A (H1N1) 2009 vaccine in mice.

Authors:  Tülin Morçӧl; Brett L Hurst; E Bart Tarbet
Journal:  Vaccine       Date:  2017-07-14       Impact factor: 3.641

2.  Comparison of complement dependent lytic, hemagglutination inhibition and microneutralization antibody responses in influenza vaccinated individuals.

Authors:  Mary Dawn T Co; John Cruz; Akira Takeda; Francis A Ennis; Masanori Terajima
Journal:  Hum Vaccin Immunother       Date:  2012-08-16       Impact factor: 3.452

3.  Differences in antibody responses between trivalent inactivated influenza vaccine and live attenuated influenza vaccine correlate with the kinetics and magnitude of interferon signaling in children.

Authors:  Raquel G Cao; Nicolas M Suarez; Gerlinde Obermoser; Santiago M C Lopez; Emilio Flano; Sara E Mertz; Randy A Albrecht; Adolfo García-Sastre; Asuncion Mejias; Hui Xu; Huanying Qin; Derek Blankenship; Karolina Palucka; Virginia Pascual; Octavio Ramilo
Journal:  J Infect Dis       Date:  2014-02-04       Impact factor: 5.226

4.  Effects of different adjuvants in the context of intramuscular and intranasal routes on humoral and cellular immune responses induced by detergent-split A/H3N2 influenza vaccines in mice.

Authors:  Mariana Baz; Mukesh Samant; Hakima Zekki; Pascale Tribout-Jover; Martin Plante; Anne-Marie Lanteigne; Marie-Eve Hamelin; Corey Mallett; Barbara Papadopoulou; Guy Boivin
Journal:  Clin Vaccine Immunol       Date:  2011-12-21

5.  Use of Multiple Imputation to Estimate the Proportion of Respiratory Virus Detections Among Patients Hospitalized With Community-Acquired Pneumonia.

Authors:  Catherine H Bozio; W Dana Flanders; Lyn Finelli; Anna M Bramley; Carrie Reed; Neel R Gandhi; Jorge E Vidal; Dean Erdman; Min Z Levine; Stephen Lindstrom; Krow Ampofo; Sandra R Arnold; Wesley H Self; Derek J Williams; Carlos G Grijalva; Evan J Anderson; Jonathan A McCullers; Kathryn M Edwards; Andrew T Pavia; Richard G Wunderink; Seema Jain
Journal:  Open Forum Infect Dis       Date:  2018-03-16       Impact factor: 3.835

6.  Seroconversion to seasonal influenza viruses after A(H1N1)pdm09 virus infection, Quebec, Canada.

Authors:  Mariana Baz; Jesse Papenburg; Marie-Eve Hamelin; Manale Ouakki; Danuta M Skowronski; Gaston De Serres; Guy Boivin
Journal:  Emerg Infect Dis       Date:  2012-07       Impact factor: 6.883

7.  Cross-lineage influenza B and heterologous influenza A antibody responses in vaccinated mice: immunologic interactions and B/Yamagata dominance.

Authors:  Danuta M Skowronski; Marie-Eve Hamelin; Naveed Z Janjua; Gaston De Serres; Jennifer L Gardy; Chantal Rhéaume; Xavier Bouhy; Guy Boivin
Journal:  PLoS One       Date:  2012-06-22       Impact factor: 3.240

8.  Sero-prevalence and incidence of A/H1N1 2009 influenza infection in Scotland in winter 2009-2010.

Authors:  Nigel J McLeish; Peter Simmonds; Chris Robertson; Ian Handel; Mark McGilchrist; Brajendra K Singh; Shona Kerr; Margo E Chase-Topping; Katy Sinka; Mark Bronsvoort; David J Porteous; William Carman; James McMenamin; Andrew Leigh-Brown; Mark E J Woolhouse
Journal:  PLoS One       Date:  2011-06-08       Impact factor: 3.240

9.  Estimating infection attack rates and severity in real time during an influenza pandemic: analysis of serial cross-sectional serologic surveillance data.

Authors:  Joseph T Wu; Andrew Ho; Edward S K Ma; Cheuk Kwong Lee; Daniel K W Chu; Po-Lai Ho; Ivan F N Hung; Lai Ming Ho; Che Kit Lin; Thomas Tsang; Su-Vui Lo; Yu-Lung Lau; Gabriel M Leung; Benjamin J Cowling; J S Malik Peiris
Journal:  PLoS Med       Date:  2011-10-04       Impact factor: 11.069

10.  Risk factors for influenza among health care workers during 2009 pandemic, Toronto, Ontario, Canada.

Authors:  Stefan P Kuster; Brenda L Coleman; Janet Raboud; Shelly McNeil; Gaston De Serres; Jonathan Gubbay; Todd Hatchette; Kevin C Katz; Mark Loeb; Donald Low; Tony Mazzulli; Andrew Simor; Allison J McGeer
Journal:  Emerg Infect Dis       Date:  2013-04       Impact factor: 6.883
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.